Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Proteome Res. 2013 Jan 31;12(3):1369–1376. doi: 10.1021/pr301023x

Figure 4. Quantitation of urinary pantothenic acid, isobutyrylcarntine, 2,8-dihydroxyquinoline and 2,8-dihydroxyquinoline-β-D-glucuronide.

Figure 4

Results were normalized to creatinine concentration. (A) Pantothenic acid in high dose tempol (250 mg/kg) and control mice from day 0 to 5. (B) Isobutyrylcarnitine in low dose tempol treatment (50 mg/kg) and control mice from day 0 to 5. (C) 2,8-Dihydroxyquinoline in low dose tempol treatment and control mice from day 0 to 5. (D) 2,8-Dihydroxyquinoline-β-D-glucuronide in low dose tempol treatment and control mice from day 0 to 5. P-values were calculated using an unpaired t-test. *P < 0.05, **P < 0.01.